IGEA Pharma NV
SIX:IGPH
IGEA Pharma NV
Other
IGEA Pharma NV
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IGEA Pharma NV
SIX:IGPH
|
Other
€499.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
107%
|
CAGR 10-Years
N/A
|
|
|
O
|
ONWARD Medical NV
XBRU:ONWD
|
Other
-€5.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
IGEA Pharma NV
Glance View
IGEA Pharma NV is a health-tech company focused on measure and control of test factors related to life-threatening diseases. The company is headquartered in Hoofddorp, Noord-Holland. The company went IPO on 2018-12-20. The firm focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The firm develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the Alzheimer’s disease. The firm offers its services in the Netherlands.
See Also
What is IGEA Pharma NV's Other?
Other
499.7k
EUR
Based on the financial report for Dec 31, 2022, IGEA Pharma NV's Other amounts to 499.7k EUR.
What is IGEA Pharma NV's Other growth rate?
Other CAGR 5Y
107%
Over the last year, the Other growth was -29%.
